HOW CONGRESS SHIELDED BIG PHARMA AND WHAT TO DO ABOUT IT
Mary Holland, Esq.
Faculty, Director, Graduate Lawyering Program NYU School of Law mary.holland@nyu.edu
1
AND WHAT TO DO ABOUT IT Mary Holland, Esq. Faculty, Director, - - PowerPoint PPT Presentation
HOW CONGRESS SHIELDED BIG PHARMA AND WHAT TO DO ABOUT IT Mary Holland, Esq. Faculty, Director, Graduate Lawyering Program NYU School of Law mary.holland@nyu.edu 1 How Did Congress Shield Pharma? Questions to Consider Why did it
Faculty, Director, Graduate Lawyering Program NYU School of Law mary.holland@nyu.edu
1
2
3
In 1980s, autism incidence 2-4 in 10,000 2009: 1 in 110 2017: 1 in 45 (1 in 68)
201
4
Encephalitis is inflammation of the brain that
when a virus or something else triggers inflammation… People may have a fever, headache, or seizures, and they may feel sleepy, numb, or confused… Encephalitis can occur in the following ways: A virus directly infects the brain. A virus that caused an infection in the past becomes reactivated and directly damages the brain. A virus or vaccine triggers a reaction that makes the immune system attack brain tissue (an autoimmune reaction).
5
6
Photo of Unanswered Questions cover
https://www.youtube.com/watch?v=6S1-LgYyjQg
1990: Mumps virus quadrupled in MMR 1990: Additional DTaP dose at younger age 1991: Three additional Hib doses 1992: Three Hep B doses 1996: Varicella (chickenpox) vaccine 2002: Flu vaccine
Timing of increased autistic disorder cumulative incidence Mc Donald & Paul, Environ. Sci. Tech., 2010 7
10
Year U.S.A Infant Mortality Rank in the World
9
10
11
12
Compulsory Medicine for School and Work:
children
Bodily Integrity/Autonomy and Informed Consent:
consent
abortion constitutional
treatment “fundamental”
unconstitutional
13
14
15
injuries)
certain”
and federal courts for fraud, negligence, malpractice, design defect claims
16
17
18
21
22
23
New Studies: Gayle DeLong, Is Delitigation Associated with a Change in Product Safety? The Case of Vaccines, Rev.
Pre-1986: 14 adverse events/100,000 vaccines administered based on VAERS Post-1986: 19.2 adverse events/100,000
2005 Public Readiness and Emergency Preparedness Act
Based on an HHS Declaration of Emergency Use Authorization
H1N1, Zika, Ebola vaccines
Law Widely recognized as unconstitutional No court review at all except in impossible circumstances No in-person hearings; all on paper HHS is the only decision maker No published decisions from the Countermeasures Injury Compensation Program
Nora F. Engstrom, A Dose of Reality for Specialized Courts: Lessons from the VICP,
163 University of Pennsylvania Law Review 1631 (2015). Stanford Law Professor
24
25
26
29
30